Showing results (1841-1850 of 6,770) with videos related to
Sort By:
Pageof 677
Clinical Therapeutics|May 23, 2002
A new approach to multicultural item generation in the development of two obesity-specific measures: the Obesity and Weight Loss Quality of Life (OWLQOL) questionnaire and the Weight-Related Symptom Measure (WRSM)Mauro Niero, Mona Martin, Thomas Finger, et al.Clinical Therapeutics|July 16, 2002
Evolving uses of hormonal agents for breast cancer therapyFrank J CummingsClinical Therapeutics|July 16, 2002
A modern rationale for the use of phenoxybenzamine in urinary tract disorders and other conditionsAlexis E TeClinical Therapeutics|July 16, 2002
Comparison of the clinical efficacy and tolerability of olopatadine hydrochloride 0.1% ophthalmic solution and loteprednol etabonate 0.2% ophthalmic suspension in the conjunctival allergen challenge modelGregg J Berdy, Juan O Stoppel, Arthur B EpsteinClinical Therapeutics|July 16, 2002
A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blockerAllen Dollar, Charles Brown, David Putnam, et al.Clinical Therapeutics|June 22, 2002
A randomized, parallel, vehicle-controlled comparison of two erythromycin/benzoyl peroxide preparations for acne vulgarisDiane Thiboutot, Michael Jarratt, Phoebe Rich, et al.Clinical Therapeutics|June 22, 2002
A postmarketing, open-label study to evaluate the tolerability and effectiveness of replacing standard-formulation doxazosin with doxazosin in the gastrointestinal therapeutic system formulation in adult patients with hypertensionMaria Anegón, Jesus Esteban, Rodrigo Jiménez-García, et al.Clinical Therapeutics|June 22, 2002
Clinical and economic outcomes associated with olanzapine for the treatment of psychotic symptoms in a county mental health populationDouglas Del Paggio, Patrick R Finley, Jeanette M CavanoClinical Therapeutics|May 17, 2003
Thalidomide: a review of approved and investigational usesS James Matthews, Christopher McCoyClinical Therapeutics|May 17, 2003
Comparison between repaglinide and glimepiride in patients with type 2 diabetes mellitus: a one-year, randomized, double-blind assessment of metabolic parameters and cardiovascular risk factorsGiuseppe Derosa, Amedeo Mugellini, Leonardina Ciccarelli, et al.Pageof 677